92 related articles for article (PubMed ID: 10628410)
21. Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays.
Black MH; Grass CL; Leinonen J; Stenman UH; Diamandis EP
Clin Chem; 1999 Mar; 45(3):347-54. PubMed ID: 10053035
[TBL] [Abstract][Full Text] [Related]
22. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
[TBL] [Abstract][Full Text] [Related]
23. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.
Pettersson K; Piironen T; Seppälä M; Liukkonen L; Christensson A; Matikainen MT; Suonpää M; Lövgren T; Lilja H
Clin Chem; 1995 Oct; 41(10):1480-8. PubMed ID: 7586521
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin.
Chen Z; Chen H; Stamey TA
J Urol; 1998 Sep; 160(3 Pt 1):870-5. PubMed ID: 9720579
[TBL] [Abstract][Full Text] [Related]
25. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
[TBL] [Abstract][Full Text] [Related]
26. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen.
Matsumoto K; Konishi N; Samori T; Kimura E; Doi M; Kato S; Yuki Y
J Immunol Methods; 2000 Feb; 234(1-2):99-106. PubMed ID: 10669774
[TBL] [Abstract][Full Text] [Related]
27. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
[TBL] [Abstract][Full Text] [Related]
28. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
[TBL] [Abstract][Full Text] [Related]
29. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J
Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
[TBL] [Abstract][Full Text] [Related]
30. Western blotting analysis of antibodies to prostate-specific antigen: specificities for prostate-specific antigen and prostate-specific antigen fragments.
Wang TJ; Linton HJ; Sokoloff RL; Grauer LS; Rittenhouse HG; Wolfert RL
Tumour Biol; 1999; 20 Suppl 1():79-85. PubMed ID: 10628413
[TBL] [Abstract][Full Text] [Related]
31. Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the TD-10 Workshop.
Nustad K; Dowell BL; Davis GJ; Stewart K; Nilsson O; Röijer E; Suminami Y; Nawata S; Cataltepe S; Silverman GA; Kato H; de Bruijn HW
Tumour Biol; 2004; 25(1-2):69-90. PubMed ID: 15192315
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the C-terminal end of the prostrate-specific antigen in a conformational epitope: characterization by proteolytic degradation of monoclonal antibody-bound antigen and mass spectrometry.
Michel S; Forest E; Pétillot Y; Deléage G; Heuzé-Vourc'h N; Courty Y; Lascoux D; Jolivet M; Jolivet-Reynaud C
J Mol Recognit; 2001; 14(6):406-13. PubMed ID: 11757074
[TBL] [Abstract][Full Text] [Related]
33. Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
Nurmikko P; Väisänen V; Piironen T; Lindgren S; Lilja H; Pettersson K
Clin Chem; 2000 Oct; 46(10):1610-8. PubMed ID: 11017939
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical characterization of 53 monoclonal antibodies to prostate-specific antigen.
Nap M; van der Kwast TM
Tumour Biol; 1999; 20 Suppl 1():38-42. PubMed ID: 10628408
[TBL] [Abstract][Full Text] [Related]
35. Epitope mapping of antibodies against prostate-specific antigen with use of peptide libraries.
Leinonen J; Wu P; Stenman UH
Clin Chem; 2002 Dec; 48(12):2208-16. PubMed ID: 12446478
[TBL] [Abstract][Full Text] [Related]
36. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
Wan XS; Xu YA; Ware JH; Kennedy AR
Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
[TBL] [Abstract][Full Text] [Related]
37. Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop.
Bjerner J; Lebedin Y; Bellanger L; Kuroki M; Shively JE; Varaas T; Nustad K; Hammarström S; Børmer OP
Tumour Biol; 2002; 23(4):249-62. PubMed ID: 12499780
[TBL] [Abstract][Full Text] [Related]
38. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.
Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H
Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101
[TBL] [Abstract][Full Text] [Related]
39. Dual monoclonal antibody immunoassay for free prostate-specific antigen.
Wang TJ; Hill TM; Sokoloff RL; Frankenne F; Rittenhouse HG; Wolfert RL
Prostate; 1996 Jan; 28(1):10-6. PubMed ID: 8545276
[TBL] [Abstract][Full Text] [Related]
40. Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997.
Rye PD; Bovin NV; Vlasova EV; Molodyk AA; Baryshnikov A; Kreutz FT; Garinther WI; Schultes BC; Noujaim AA; Madiyalakan R; Magnani J; Nilsson O; Nilsson K; Nustad K; Norum L; Bell H; Cao Y; Suresh MR; Very DL; Freeman JV; Yeung KK; Hilgers J
Tumour Biol; 1998; 19(5):390-420. PubMed ID: 9701730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]